Loading memory…
Loading memory…
Patent portfolio assigned to Multiply Labs (verified via public assignee records). Cloud-controlled robotic systems for cell-therapy / pharma manufacturing. Partners named in Multiply Labs press releases (BioSpace) and own site (Kyverna). Cellares and Ori Biotech are named as cell-therapy automation competitors in FiercePharma coverage. Patents confirmed: 'MULTIPLY LABS INC.' is a Justia patent assignee.